Trademark: 77343408
Word
LIPOINT
Status
Dead
Status Code
606
Status Date
Tuesday, July 5, 2011
Serial Number
77343408
Mark Type
4000
Filing Date
Tuesday, December 4, 2007
Published for Opposition
Tuesday, September 8, 2009
Abandoned Date
Tuesday, July 5, 2011

Trademark Owner History
LiPoint Inc. - Owner At Publication

Classifications
5 Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Almond oil for pharmaceutical purposes; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Unit dose capsules sold empty for pharmaceutical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes,and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations namely,antidepressants; Pharmaceutical preparations namely,appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Almond oils for pharmaceutical purposes; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Antimicrobial preservatives for cosmetics and pharmaceuticals; Astringents; Cardiovascular pharmaceuticals
10 Injection device for pharmaceuticals; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical apparatus for introducing pharmaceutical preparations into the human body
42 Pharmaceutical drug development services; Research and development of vaccines and medicines; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research on the subject of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff

Trademark Events
Jul 5, 2011
Abandonment Notice Mailed - No Use Statement Filed
Jul 5, 2011
Abandonment - No Use Statement Filed
Jan 31, 2011
Withdrawal Of Attorney Granted
Jan 31, 2011
Teas Withdrawal Of Attorney Received
Dec 21, 2010
Notice Of Approval Of Extension Request Mailed
Dec 20, 2010
Extension 2 Granted
Dec 1, 2010
Extension 2 Filed
Dec 20, 2010
Case Assigned To Intent To Use Paralegal
Dec 1, 2010
Teas Extension Received
Jun 3, 2010
Notice Of Approval Of Extension Request Mailed
Jun 1, 2010
Extension 1 Granted
Jun 1, 2010
Extension 1 Filed
Jun 1, 2010
Teas Extension Received
Dec 1, 2009
Noa Mailed - Sou Required From Applicant
Sep 8, 2009
Published For Opposition
Aug 19, 2009
Notice Of Publication
Aug 6, 2009
Law Office Publication Review Completed
Aug 5, 2009
Assigned To Lie
Jul 28, 2009
Approved For Pub - Principal Register
Jul 24, 2009
Teas/Email Correspondence Entered
Jul 23, 2009
Correspondence Received In Law Office
Jul 23, 2009
Teas Response To Office Action Received
Feb 3, 2009
Attorney Revoked And/Or Appointed
Feb 3, 2009
Teas Revoke/Appoint Attorney Received
Jan 23, 2009
Notification Of Non-Final Action E-Mailed
Jan 23, 2009
Non-Final Action E-Mailed
Jan 23, 2009
Non-Final Action Written
Jan 5, 2009
Teas Change Of Correspondence Received
Jan 5, 2009
Petition To Revive-Granted
Jan 5, 2009
Teas Petition To Revive Received
Nov 6, 2008
Abandonment Notice Mailed - Failure To Respond
Nov 6, 2008
Abandonment - Failure To Respond Or Late Response
Mar 14, 2008
Notification Of Non-Final Action E-Mailed
Mar 14, 2008
Non-Final Action E-Mailed
Mar 14, 2008
Non-Final Action Written
Mar 14, 2008
Assigned To Examiner
Dec 7, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24